ProCE Banner Activity

Expert Insights Into HER2 Testing for Advanced Breast, GI, and Lung Cancers

Slideset

Download this slideset for expert perspectives and guideline recommendations on HER2 testing to inform targeted therapy for patients with advanced breast, gastroesophageal, colorectal, and lung cancers. 

Released: March 25, 2024

Expiration: March 24, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, and Seagen.

AstraZeneca

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals

Seagen